Literature DB >> 20727908

ERG changes in albino and pigmented mice after optic nerve transection.

Luis Alarcón-Martínez1, Marcelino Avilés-Trigueros, Caridad Galindo-Romero, Javier Valiente-Soriano, Marta Agudo-Barriuso, Pedro de la Villa, Maria P Villegas-Pérez, Manuel Vidal-Sanz.   

Abstract

Optic nerve transection (ONT) triggers retinal ganglion cell (RGC) death. By using this paradigm, we have analyzed for the first time in adult albino and pigmented mice, the effects of ONT in the scotopic threshold response (STR) components (negative and positive) of the full-field electroretinogram. Two weeks after ONT, when in pigmented mice approximately 18% of the RGC population survive, the STR-implicit time decreased and the p and nSTR waves diminished approximately to 40% or 55%, in albino or pigmented, respectively, with respect to the values recorded from the non-operated contralateral eyes. These changes were maintained up to 12 weeks post-ONT, demonstrating that the ERG-STR is a useful parameter to monitor RGC functionality in adult mice.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20727908     DOI: 10.1016/j.visres.2010.08.014

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  23 in total

1.  Contribution of retinal ganglion cells to the mouse electroretinogram.

Authors:  Benjamin J Smith; Xu Wang; Balwantray C Chauhan; Patrice D Côté; François Tremblay
Journal:  Doc Ophthalmol       Date:  2014-06       Impact factor: 2.379

2.  The bugeye mutant zebrafish exhibits visual deficits that arise with the onset of an enlarged eye phenotype.

Authors:  Joseph M Stujenske; John E Dowling; Farida Emran
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-13       Impact factor: 4.799

3.  Molecular, anatomical and functional changes in the retinal ganglion cells after optic nerve crush in mice.

Authors:  Masayoshi Yukita; Shigeki Machida; Koji M Nishiguchi; Satoru Tsuda; Yu Yokoyama; Masayuki Yasuda; Kazuichi Maruyama; Toru Nakazawa
Journal:  Doc Ophthalmol       Date:  2015-01-06       Impact factor: 2.379

4.  Reprogramming amacrine and photoreceptor progenitors into retinal ganglion cells by replacing Neurod1 with Atoh7.

Authors:  Chai-An Mao; Jang-Hyeon Cho; Jing Wang; Zhiguang Gao; Ping Pan; Wen-Wei Tsai; Laura J Frishman; William H Klein
Journal:  Development       Date:  2013-02-01       Impact factor: 6.868

5.  Structural and functional effects of hemiretinal endodiathermy axotomy in cynomolgus macaques.

Authors:  Ryan J Dashek; Charlene B Y Kim; Carol A Rasmussen; Elizabeth A Hennes-Beean; James N Ver Hoeve; T Michael Nork
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-17       Impact factor: 4.799

Review 6.  Evaluating retinal ganglion cell loss and dysfunction.

Authors:  Ben Mead; Stanislav Tomarev
Journal:  Exp Eye Res       Date:  2016-08-12       Impact factor: 3.467

7.  Diffuse traumatic axonal injury in the optic nerve does not elicit retinal ganglion cell loss.

Authors:  Jiaqiong Wang; Michael A Fox; John T Povlishock
Journal:  J Neuropathol Exp Neurol       Date:  2013-08       Impact factor: 3.685

8.  Critical Role of the CXCL10/C-X-C Chemokine Receptor 3 Axis in Promoting Leukocyte Recruitment and Neuronal Injury during Traumatic Optic Neuropathy Induced by Optic Nerve Crush.

Authors:  Yonju Ha; Hua Liu; Shuang Zhu; Panpan Yi; Wei Liu; Jared Nathanson; Rakez Kayed; Bradford Loucas; Jiaren Sun; Laura J Frishman; Massoud Motamedi; Wenbo Zhang
Journal:  Am J Pathol       Date:  2016-12-10       Impact factor: 4.307

9.  Quantification of Changes in Visual Function During Disease Development in a Mouse Model of Pigmentary Glaucoma.

Authors:  Stephanie L Grillo; Christa L Montgomery; Heather M Johnson; Peter Koulen
Journal:  J Glaucoma       Date:  2018-09       Impact factor: 2.503

10.  AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma.

Authors:  Nicolas Belforte; Jessica Agostinone; Luis Alarcon-Martinez; Deborah Villafranca-Baughman; Florence Dotigny; Jorge L Cueva Vargas; Adriana Di Polo
Journal:  Mol Neurodegener       Date:  2021-06-29       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.